Cover: The International AIDS Vaccine Initiative's capacity building activities in East Africa

The International AIDS Vaccine Initiative's capacity building activities in East Africa

Evaluating progress and impacts in Kenya, Uganda and Rwanda

Published Jul 30, 2015

by Gavin Cochrane, Enora Robin, Rebecca Hanlin, Sophie Castle-Clarke, Calum MacLure, Sarah Parks, Joanna Chataway

Download eBook for Free

Full Document

FormatFile SizeNotes
PDF file 5.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

أنشطة بناء القدرات في إطار المبادرة الدولية بشأن لقاح الإيدز في شرق أفريقيا: تقييم التقدم والآثار المحرزة في كينيا وأوغندا ورواندا

Arabic language version

FormatFile SizeNotes
PDF file 5.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

The International AIDS Vaccine Initiative (IAVI) is one of a number of Product Development Partnerships created to bridge the gap between scientific and technological potential and the needs of low income populations in low and middle income countries. Specifically IAVI is focused on creating a preventative vaccine for HIV/AIDS. Whilst the remit of IAVI is to create new science, technology and products, its work necessarily involves a wide range of stakeholders and different constituencies in industrially developing and developed countries. Its capacity building activities relate to strengthening the ability to conduct clinical trials and are broad based, spanning scientific and technological capacity through to organisational, advocacy and broader development capabilities. The aim of this study was to deepen IAVI's understanding of how it contributes to capacity building activities in East Africa (Uganda, Kenya, and Rwanda), spanning scientific and technological capacity through to organisational, advocacy and broader development capabilities.

IAVI's mission to develop an HIV vaccine has become increasingly connected to wider health systems strengthening, through its clinical research activities in East Africa. Since it began its operations in the region, IAVI have made a significant contribution to training interventions to support scientific excellence and good clinical practice and invested in infrastructure and laboratories at Clinical Research Centres in East Africa. Although clear challenges still exist with ensuring sustained investment, accessing marginalized populations and demonstrating progress in capacity building, the experiences of IAVI to date suggest that substantial progress is being made towards wider health systems strengthening in the region.

Research conducted by

The research described in this report was prepared for the International AIDS Vaccine Initiative and conducted by RAND Europe.

This report is part of the RAND research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.